Paul Wyckoff
CEMTREXAbout Paul Wyckoff
Paul J. Wyckoff is Chief Financial Officer of Cemtrex (appointed January 6, 2025) after serving as Interim CFO since January 28, 2022; he joined Cemtrex in March 2014 and holds a B.S. in Accounting from SUNY College at Old Westbury . He is 55 years old per the 2025 proxy . Context during his finance leadership: revenues rose from $45.0M in FY2022 to $66.9M in FY2024, while net losses improved from $(13.29)M to $(7.64)M; shareholder TSR (value of initial $100) was $18.10 (FY2022), $65.03 (FY2023), and $2.53 (FY2024) . He is responsible for financial planning, accounting, tax, and business process functions .
Past Roles
| Organization | Role | Years | Strategic impact / scope |
|---|---|---|---|
| Cemtrex | Chief Financial Officer | Jan 6, 2025 – Present | Responsible for financial planning, accounting, tax, and business process functions . |
| Cemtrex | Interim Chief Financial Officer | Jan 28, 2022 – Jan 6, 2025 | Led finance function during transition period . |
| Cemtrex | Corporate Controller | Jan 2019 – Jan 2022 | Corporate Controller . |
| Cemtrex | Manager of Financial Reporting | Mar 2014 – Jan 2019 | Manager of Financial Reporting . |
External Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Vaso Corporation (formerly Vasomedical, Inc.) | Controller | Pre-2014 (prior to joining Cemtrex in Mar 2014) | Controller at a medical device distribution company . |
The Company disclosed Mr. Wyckoff has not held other public company directorships in the past five years .
Fixed Compensation
| Component | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Base Salary ($) | 97,615 | 150,000 | 150,000 |
| Target Bonus (%) | Not disclosed | Not disclosed | Not disclosed |
| Actual Bonus Paid ($) | – | – | – |
| Other Compensation ($) | 4,557 (benefits) | 12,291 (benefits) | 15,853 (benefits) |
| Total ($) | 102,172 | 162,291 | 165,853 |
Company states there is no employment agreement with Mr. Wyckoff; all amounts approved by the Board .
Performance Compensation
- No annual cash incentive plan payouts disclosed for Mr. Wyckoff in FY2022–FY2024 .
- No stock awards or option grants disclosed for Mr. Wyckoff in these years; the “Options/SAR Grants,” “Aggregated Option Exercises,” and “Outstanding Equity Awards” sections list no awards for him (only CEO options are listed) .
Equity Ownership & Alignment
| Metric | As of Mar 18, 2024 | As of Mar 18, 2025 |
|---|---|---|
| Common Shares Beneficially Owned (#) | 0 | 0 |
| Ownership of Common (% of class) | <1% (starred as less than 1%) | <1% (starred as less than 1%) |
| Series 1 Preferred Owned (#) | 0 | 0 |
| Series C Preferred Owned (#) | 0 | 0 |
- Options/RSUs: No outstanding equity awards reported for Mr. Wyckoff as of September 30, 2024 (only CEO holdings shown) .
- Pledging/Hedging: The company references an insider trading policy; no specific disclosure of share pledging by Mr. Wyckoff was found .
- Ownership guidelines: Not disclosed.
Employment Terms
- Employment agreement: None; company states it may enter into agreements in the future; no “key man” insurance .
- Severance / Change-in-control: Not disclosed in proxy/10-K .
- Clawback policy: Not disclosed; company references a Code of Ethics .
- Non-compete / Non-solicit / Garden leave / Post-termination consulting: Not disclosed .
- “Controlled Company”: Cemtrex is a NASDAQ “Controlled Company” and does not maintain a Compensation Committee .
Performance & Track Record (context during his finance leadership)
| Metric | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Revenues ($) | 45,026,780 | 59,368,562 | 66,863,884 |
| Net Loss ($) | (13,292,242) | (9,233,438) | (7,635,505) |
| Value of $100 Initial Investment (TSR) ($) | 18.10 | 65.03 | 2.53 |
Additional governance/controls context:
- Management concluded internal control over financial reporting was effective as of Sept 30, 2024; no material weaknesses reported .
- The auditor included a going-concern emphasis due to continuing losses and short-term debt obligations .
Investment Implications
- Alignment: Zero reported equity ownership and absence of performance-based incentives reduce direct pay-for-performance alignment and may limit long-term retention incentives for the CFO .
- Selling pressure: With no reported equity holdings or outstanding awards, near-term insider selling pressure from Mr. Wyckoff appears minimal .
- Retention risk: Lack of an employment agreement implies limited severance/change-in-control protections; this can cut both ways—cost control for shareholders but potentially higher turnover risk in a challenging, going-concern environment .
- Execution risk: While revenue expanded FY2022–FY2024 and net losses narrowed, TSR deteriorated in FY2024, underscoring capital market and execution risks that the finance function must navigate amid going-concern headwinds .